Business Wire

  1. Dr. Reddy's Formally Announces Its U.S. Specialty Business, Promius Pharma, LLC 9/19/2008
    Dr. Reddy's Laboratories today formally announced its US Specialty Business with the launch of Promius Pharma, a wholly-owned subsidiary of Dr. Reddy's Laboratories located in Bridgewater, NJ.
  2. Neose Technologies To Sell Its Assets To Novo Nordisk And BioGeneriX 9/18/2008
    Neose Technologies, Inc. today announced that it has signed definitive asset purchase agreements with Novo Nordisk A/S and BioGeneriX AG providing for the sale of substantially all of the assets of Neose in all-cash transactions for an aggregate purchase price of approximately $43M.
  3. Pfizer Launches New Medicine Safety Website To Help Healthcare Professionals And Patients Make Better Informed Decisions About Treatment Options 9/15/2008
    Pfizer Inc announced today the launch of a new interactive online educational resource designed to give healthcare professionals, medical students, patients, patient advocates and the general public more information about medicine safety, and, in turn, more confidence when making decisions about appropriate treatment options.
  4. A Detailed Analysis Of The OTC Market Central And Eastern Europe 2008: Including A Comparative Analysis And Forecasts To 2010 9/11/2008
    Research and Markets has announced the addition of the "OTC Market in Central and Eastern Europe 2008: Comparative Analysis and Development Forecasts for 2008-2010" report to their offering.
  5. Big Pharma Looks For Strategies To Fight The Decline 9/10/2008
    In an effort to survive declining profits and drug failures, the pharmaceutical industry is turning to layoffs and outsourcing.
  6. APP Pharmaceuticals Announces Completion Of Acquisition By Fresenius 9/10/2008
    APP Pharmaceuticals, Inc., formerly traded on the NASDAQ Capital Market under the symbol APPX, today announced that Fresenius Kabi, a business segment of Fresenius SE, has completed its acquisition of APP. The official close date is September 10, 2008.
  7. Alternative Drug Delivery Systems Key For European hGH Market 9/10/2008
    With the approval of biosimilars in Europe, the overall cost of human growth hormone (hGH) treatment has reduced by more than 25 per cent.
  8. New Report By URCH Publishing Highlights The Likely Shape Of Global Pharmaceutical Manufacturing Over The Next Decade 9/9/2008
    Identifying acceptable levels of risk will increasingly be at the heart of global pharmaceutical companies' manufacturing strategy, says a new report from URCH Publishing.
  9. Akorn, Inc. Announces First Lyophilized Product Approval For Decatur, IL: IC-Green™ For Injection, USP 9/9/2008
    Akorn, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted supplemental NDA approval for IC-Green™ for Injection, USP. This approval is Akorn’s first lyophilized product approval for manufacture in its Decatur, IL production facility.
  10. Indian Pharma Industry Monitor Delivers Complete Summary And Analysis Of The Indian Pharma Market 9/4/2008
    Research and Markets has announced the addition of the "Indian Pharma Industry Monitor" report to their offering.